BA-60-RH02_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, 3-(4-(8-Amino-3-tert-butylimidazo(1,5-a)pyrazin-1-yl)naphthalen-1-yl)-1-(3-(trifluoromethyl)phenyl)urea, IRE1 RNase Allosteric Inhibitor targeting ERN1 (Novartis, 73425700)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/73425700
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the BA-60-RH02_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
CCNI cyclin I 1.29448
PRR11 proline rich 11 0.507049
AKR1B15 aldo-keto reductase family 1, member B15 0.334033
ZKSCAN1 zinc finger with KRAB and SCAN domains 1 0.251305
ORAI2 ORAI calcium release-activated calcium modulator 2 0.236988
TRIOBP TRIO and F-actin binding protein 0.210283

decreased expression

Symbol Name Standardized Value
SF3B6 splicing factor 3b, subunit 6, 14kDa -1.30181
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle -0.772254
ZNF740 zinc finger protein 740 -0.630503
LRRC37B leucine rich repeat containing 37B -0.303166
MAGED1 melanoma antigen family D1 -0.27698
FHL2 four and a half LIM domains 2 -0.261903
LDHB lactate dehydrogenase B -0.236988
RAB5IF RAB5 interacting factor -0.236988